Globus Medical, Inc. (GMED)

Globus Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	371.77	784.44	467.29	150.47	193.07	239.4
Short-Term Investments	18.75	105.62	50.5	295.59	250.38	187.34
Cash & Short-Term Investments	390.52	890.06	517.79	446.06	443.45	426.74
Cash Growth	-43.79%	71.90%	16.08%	0.59%	3.91%	37.00%
Accounts Receivable	619.12	557.7	503.24	213.25	164.44	141.68
Other Receivables	69.01	20.63	1.64	4.06	1.22	6.42
Receivables	688.12	578.33	504.87	217.31	165.65	148.1
Inventory	771.54	659.23	848.14	298.98	237	229.15
Prepaid Expenses	74.18	49.64	44.58	21	18.42	17.77
Total Current Assets	1,924	2,177	1,915	983.34	864.52	821.77
Property, Plant & Equipment	637.92	612.07	647.66	249.72	221.08	221.62
Long-Term Investments	16.68	66.13	75.43	495.85	562.48	358.52
Goodwill	1,434	1,432	1,435	197.47	179.71	156.72
Other Intangible Assets	773.9	795.12	924.6	63.57	68.66	86.95
Long-Term Deferred Tax Assets	232.36	94.2	10.69	48.85	24.49	6.62
Other Long-Term Assets	76.12	74.58	77.79	37.32	36.33	27.3
Total Assets	5,096	5,252	5,086	2,076	1,957	1,679
Accounts Payable	87.23	75.12	56.67	36.1	21.96	18.21
Accrued Expenses	286.7	253.61	230.65	86.61	87.24	85.07
Current Portion of Long-Term Debt	-	443.35	-	-	-	-
Current Portion of Leases	14.7	10.48	12.44	2.54	-	1.87
Current Income Taxes Payable	1.29	10.73	3.85	0.99	1.05	1.1
Current Unearned Revenue	18.27	22.14	18.37	14.1	12.03	8.13
Other Current Liabilities	57.78	40.49	70.37	18.87	17.89	6.43
Total Current Liabilities	465.96	855.91	392.35	159.2	140.16	120.79
Long-Term Debt	-	-	417.4	-	-	-
Long-Term Leases	105.42	83.89	91.37	3.48	-	2.94
Long-Term Deferred Tax Liabilities	22.54	23.89	84.42	1.78	4.31	6.2
Other Long-Term Liabilities	102.9	110.73	102.58	65.3	71.4	43.26
Total Liabilities	696.82	1,074	1,088	229.75	215.88	173.19
Common Stock	0.13	0.14	0.14	0.1	0.1	0.1
Additional Paid-In Capital	3,095	3,031	2,871	630.95	553.79	457.16
Retained Earnings	1,292	1,153	1,137	1,240	1,194	1,045
Comprehensive Income & Other	10.93	-6.86	-10.19	-24.63	-6.77	3.96
Shareholders' Equity	4,399	4,177	3,998	1,846	1,741	1,506
Total Liabilities & Equity	5,096	5,252	5,086	2,076	1,957	1,679
Total Debt	120.11	537.72	521.22	6.01	-	4.8
Net Cash (Debt)	287.09	418.47	72	935.9	1,006	780.46
Net Cash Growth	68.19%	481.20%	-92.31%	-6.96%	28.89%	8.62%
Net Cash Per Share	2.08	3.04	0.63	9.12	9.71	7.73
Filing Date Shares Outstanding	133.84	137.54	135.37	100.3	101.56	99.8
Total Common Shares Outstanding	134.61	137.42	136.34	100.19	101.54	99.71
Working Capital	1,458	1,321	1,523	824.14	724.35	700.97
Book Value Per Share	32.68	30.40	29.32	18.43	17.15	15.11
Tangible Book Value	2,191	1,950	1,639	1,585	1,493	1,263
Tangible Book Value Per Share	16.27	14.19	12.02	15.82	14.70	12.66
Land	9.77	9.73	9.75	8.28	8.3	8.32
Buildings	125.36	100.13	102.45	51.51	44.67	33.83
Machinery	1,027	956.23	878.41	508.88	443.25	423.4

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q